SEC Comment Letter 0000000000-24-005989 to Pulmatrix, Inc. (PULM)
Pulmatrix, Inc.
Date: May 23, 2024 · CIK: 0001574235 · Accession: 0000000000-24-005989
AI Filing Summary & Sentiment
File numbers found in text: 333-279491
Letter
United States securities and exchange commission logo May 23, 2024 Teofilo Raad Chief Executive Officer and President Pulmatrix, Inc. 36 Crosby Drive, Suite 100 Bedford, MA 01730 Re:Pulmatrix, Inc. Registration Statement on Form S-3 Filed May 17, 2024 File No. 333-279491 Dear Teofilo Raad: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jimmy McNamara at 202-551-7349 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Rick Werner
Show Raw Text
United States securities and exchange commission logo
May 23, 2024
Teofilo Raad
Chief Executive Officer and President
Pulmatrix, Inc.
36 Crosby Drive, Suite 100
Bedford, MA 01730
Re:Pulmatrix, Inc.
Registration Statement on Form S-3
Filed May 17, 2024
File No. 333-279491
Dear Teofilo Raad:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jimmy McNamara at 202-551-7349 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Rick Werner